I’m still confused (or using stronger language not convinced) by their messaging on what is live and what is earning revenue.
The headline of this announcement is ePrescribing. Then a one liner at the bottom, promoting Adheris going live and Day Lewis launching their app.
This Australian development is on the back of MedAdvisor recently going live with digital health programs in the USA (Q4 FY20) and launching an app in the UK through its key partnership with Day Lewis Pharmacy (Q1 FY21).
Why is ePrescribing a bigger milestone than the much talked about first UK customer?
Why isn’t Day Lewis promoting this on their social media?
https://mobile.twitter.com/daylewisgroup
Why can’t the app be found in the UK App Store?
Or will it go live in the remaining 8 days of Q1FY21?
Why are partners products ‘going live’ without payments being made?
Announcements are stating solutions being delivered but have only mentioned ‘green shoot revenue’.
September quarter should reveal all, as numbers tell the story, not wordy announcements.
Add to My Watchlist
What is My Watchlist?
